ImaRx Pharmaceutical, Inc.

Healthcare & Life SciencesCapital Raise
Written By Emily Dyer-Wolfe
ImaRX.png

ImaRx Pharmaceutical, Inc.

ImaRx Therapeutics, Inc., a Tucson, AZ pharmaceutical development company raised $15 million in preferred equity. Funding was provided by Solstice Capital, a Boston, MA venture capital firm. The proceeds from the offering was used to augment the Company's product development efforts as well as working capital.

Emily Dyer-Wolfe
Previous

ImaRx Pharmaceutical, Inc.
Next

Dako